Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

688091 Shanghai Yizhong Pharmaceutical

Watchlist
72.810
-1.200-1.62%
Market Close  12/06 15:00 CCT
High
74.880
Open
73.530
Turnover
74.34M
Low
72.730
Pre Close
74.010
Volume
10.09Klot
Market Cap
10.48B
P/E(TTM)
87.09
52wk High
146.234
Shares
143.89M
P/E(Static)
Loss
52wk Low
31.654
Float Cap
7.59B
Bid/Ask %
-51.04%
Historical High
146.234
Shs Float
104.19M
Volume Ratio
0.67
Historical Low
28.250
Dividend TTM
--
Div Yield TTM
--
P/B
11.13
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.97%
Amplitude
2.91%
Avg Price
73.661
Lot Size
100
Float Cap
7.59B
Bid/Ask %
-51.04%
Historical High
146.234
Shs Float
104.19M
Volume Ratio
0.67
Historical Low
28.250
Dividend TTM
--
Limit Up
88.810
P/B
11.13
Dividend LFY
--
Limit Down
59.210
Turnover Ratio
0.97%
Amplitude
2.91%
Avg Price
73.661
Lot Size
100
Ask
5.97Klot
Bid
4.18Klot
Price Forecast

News

Comment

Company Overview More
The company is committed to the development of new dosage forms of antineoplastic drugs and related products. The company is committed to the R & D and industrialization of improved new drugs for antineoplastic drugs, with high-tech talents with the background of polymer materials, pharmaceutical preparations and biology, and mastering the core and key technologies for the synthesis of nano-drug carriers and medicinal polymer excipients. The company's main research and development product is paclitaxel micelles. Paclitaxel micelle is an innovative lyophilized powder injection without polyoxyethylene castor oil and methoxy polyethylene glycol 2000-poly (lactide) copolymer as carrier.
CEO: Jingsong Zhou
Market: --
Listing Date: 09/09/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist